JPH0621064B2 - Antiparasitic agent containing xanthocillin X monomethyl ether - Google Patents

Antiparasitic agent containing xanthocillin X monomethyl ether

Info

Publication number
JPH0621064B2
JPH0621064B2 JP18672088A JP18672088A JPH0621064B2 JP H0621064 B2 JPH0621064 B2 JP H0621064B2 JP 18672088 A JP18672088 A JP 18672088A JP 18672088 A JP18672088 A JP 18672088A JP H0621064 B2 JPH0621064 B2 JP H0621064B2
Authority
JP
Japan
Prior art keywords
xanthocillin
monomethyl ether
administration
agent containing
anthelmintic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP18672088A
Other languages
Japanese (ja)
Other versions
JPH0240324A (en
Inventor
誠之 高木
徹 佐々木
慎二 宮道
忠昭 岡田
喬 庄村
正次 瀬崎
直利 赤井
重治 井上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Priority to JP18672088A priority Critical patent/JPH0621064B2/en
Publication of JPH0240324A publication Critical patent/JPH0240324A/en
Publication of JPH0621064B2 publication Critical patent/JPH0621064B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Description

【発明の詳細な説明】 産業上の利用分野 本発明は下記の化学構造式で示される公知の抗生物質,
キサントシリンXモノメチルエーテルの用途に関するも
のである。さらに詳しくは,キサントシリンXモノメチ
ルエーテルを含有する家畜家禽等の寄生虫の駆虫剤に関
するものである。
The present invention relates to a known antibiotic represented by the following chemical structural formula,
It relates to the use of xanthocillin X monomethyl ether. More specifically, it relates to an anthelmintic agent for parasites such as livestock and poultry containing xanthocillin X monomethyl ether.

従来の技術 駆虫作用を有する化合物は多数知られており,本物質の
如く微生物の生産物で駆虫活性を有する物質としては,
デストマイシン,ハイグロマイシン,アベルメクチン等
が挙げられる。
BACKGROUND ART A large number of compounds having anthelmintic activity are known, and as a substance having anthelmintic activity in a microbial product such as this substance,
Destomycin, hygromycin, avermectin and the like can be mentioned.

発明が解決しようとする課題 前記のとおり多数の駆虫剤が知られているが,寄生虫病
は,豚,馬,牛,羊,山羊,犬,猫等の家畜動物や鶏な
どの家禽動物において現在も流行しており,かつ経済的
に深刻な問題である。
Problems to be Solved by the Invention Although a large number of anthelmintic agents are known as described above, parasitic disease is caused in domestic animals such as pigs, horses, cows, sheep, goats, dogs, cats, and poultry animals such as chickens. It is still in fashion and is a serious economic problem.

すなわち寄生虫の感染によって、感染動物は貧血症,栄
養不良,虚弱,体重の減少,胃,腸管壁および他の組
織,器官の損傷をひきおこし,飼料効率の低下,生産性
低下の原因のひとつとなって経済的損失が大きい。従っ
て,新規な駆虫剤を提供することは常に求められている
課題である。
Infection of parasites causes anemia, malnutrition, weakness, weight loss, damage to the stomach, intestinal wall and other tissues and organs, which is one of the causes of reduced feed efficiency and reduced productivity. The economic loss is large. Therefore, providing a new anthelmintic agent is always a challenge.

課題を解決するための手段 前記の問題点を解決するために本発明はキサントシリン
Xモノメチルエーテル[1−(p-ヒドロキシフェニル)-
2,3-ジイソシアノ-4−(p-メトキシフェニル)-ブタ
−1,3-ジエン]を含有する駆虫剤を提供するものであ
る。キサントシリンXモノメチルエーテルはK.Andoら
(J.Antibiotics 21,582〜587,1968)によって既に報告
されている公知の抗生物質で,ジコトモミセス・アルブ
ス(Dichotomomyces albus),アスペルギルス属(Aspergi
llus sp.)等のカビの培養液から得られた物質である。
Means for Solving the Problems In order to solve the above-mentioned problems, the present invention provides xanthocillin X monomethyl ether [1- (p-hydroxyphenyl)-
2,3-diisocyano-4- (p-methoxyphenyl) -but-1,3-diene] is provided. Xanthocillin X monomethyl ether is K. Ando et al.
(J. Antibiotics 21 , 582-587, 1968), a known antibiotic that has already been reported by Dichotomomyces albus, Aspergis.
llus sp.) and other fungal culture solutions.

本物質はグラム陽性菌および陰性菌に対する抗菌活性,
ニューキャッスル病ウイルスおよびヘルペスウイルス等
に対する抗ウイルス作用,さらにはプロスタグランジン
の合成阻害および血小板凝集抑制作用等の活性を有する
ことが知られている。
This substance has antibacterial activity against Gram-positive and negative bacteria,
It is known to have antiviral activity against Newcastle disease virus, herpes virus, etc., as well as activities such as prostaglandin synthesis inhibition and platelet aggregation inhibition.

しかし,われわれは今回新たに本物質が動物の寄生虫に
対する駆虫活性を有することを発見した。
However, we have now discovered that the substance has anthelmintic activity against animal parasites.

キサントシリンXモノメチルエーテルを駆虫剤として適
用しようとする動物は豚,馬,兎,牛,羊,山羊,鶏,
アヒル,七面鳥,二十日ネズミ,大黒ネズミ,モルモッ
ト,サル,犬,猫,小鳥等の家畜,家禽,実験動物,ペ
ット等を挙げることができる。また,これらの動物の寄
生虫としては,たとえば,犬,猫,牛,山羊,馬,鶏の
条虫,馬,豚,犬,猫,鶏の回虫,馬の蟯虫,馬,豚,
羊,山羊の桿虫,豚,羊,犬の鞭虫,馬の円虫,牛,
豚,羊,山羊の腸結節虫,牛,羊,犬の十二指腸虫(鉤
虫),牛,豚,羊,山羊の毛様線虫,牛,馬,羊,山羊
の胃虫,鶏,七面鳥,アヒルの毛体虫と盲腸虫,牛,
馬,羊,山羊,犬の糸状虫,牛,馬,羊,山羊,豚,
犬,猫の肝臓に寄生する肝蛭と消火器系に寄生する双口
吸虫などの吸虫類,その他,種々の寄生虫が知られてい
る。
Animals to which xanthocillin X monomethyl ether is applied as an anthelmintic agent are pigs, horses, rabbits, cows, sheep, goats, chickens,
Examples thereof include domestic animals such as ducks, turkeys, twentieth mice, daikoku rats, guinea pigs, monkeys, dogs, cats, small birds, poultry, laboratory animals, and pets. Examples of parasites of these animals include dogs, cats, cows, goats, horses, chicken tapeworms, horses, pigs, dogs, cats, roundworms of horses, pinworms of horses, horses, pigs,
Sheep, goat rodworm, pig, sheep, dog whipworm, horse roundworm, cow,
Pig, sheep, goat intestinal tuberculosis, cow, sheep, dog's duodenum (hookworm), cow, pig, sheep, goat's hairy nematode, cow, horse, sheep, goat's gastropod, chicken, turkey, Duck caterpillars and cecal worms, cattle,
Horses, sheep, goats, worms of dogs, cows, horses, sheep, goats, pigs,
Various parasites are known, such as flukes that parasitize the livers of dogs and cats, and flukes such as double-mouth flukes that parasitize the fire extinguisher system.

キサントシリンXモノメチルエーテルは寄生虫感染症の
治療および予防のために用いることができる。治療のた
めの投与方法は経口的又は非経口的な方法がある。経口
的に投与する場合は,液状の製剤を胃ゾンデ等の投与器
具を用いて強制的に投与する方法,通常の飼料又は飲料
水に混合して投与する方法,又は,通常の経口投与に適
した剤型,例えば錠剤,カプセル剤,ペレット剤,巨丸
剤,粉剤あるいは軟カプセル剤等の剤形で投与する方法
がある。非経口的に投与する場合は,ピーナッツ油,大
豆油等の非水溶性処方,グリセロール,ポリエチレング
リコール等の水溶性処方を注射などにより皮下,筋肉
内,静脈内,腹腔内等に投与する。また,寄生虫の予防
のための投与方法は通常用いられている飼料に混合し経
口的に投与するのが一般的な方法である。投与期間は予
防の場合特に制限がないが,通常肉用鶏では約2か月,
豚では5か月で充分であることが多い。
Xanthocillin X monomethyl ether can be used for the treatment and prevention of parasitic infections. The administration method for treatment includes an oral or parenteral method. When administered orally, it is suitable for forced administration of liquid preparations using an administration device such as a gastric tube, administration by mixing with normal feed or drinking water, or ordinary oral administration There is a method of administration in a dosage form such as tablets, capsules, pellets, boluses, powders or soft capsules. When administered parenterally, a water-insoluble formulation such as peanut oil or soybean oil, or a water-soluble formulation such as glycerol or polyethylene glycol is administered subcutaneously, intramuscularly, intravenously, intraperitoneally, etc. by injection. In addition, the general method of administration for the prevention of parasites is to mix it with a commonly used feed and administer it orally. The administration period is not particularly limited for prevention, but it is usually about 2 months for meat chickens,
For pigs, 5 months is often sufficient.

キサントシリンXモノメチルエーテルの投与量は対象動
物および寄生虫の種類,あるいは投与方法により異な
る。例えば,鶏の回虫を駆除するために液状製剤を胃ゾ
ンデを用いて経口的に投与する場合は5mg/kg以上,好
ましくは5mg/kg〜20mg/kgを投与する。また,予防の
ための投与量は飼料中5ppm 以上が好ましく5ppm〜20p
pmの濃度で連続的に投与する。
The dose of xanthocillin X monomethyl ether varies depending on the type of target animal and parasite or the administration method. For example, when a liquid preparation is orally administered using a gastric tube to control Ascaris suum, 5 mg / kg or more, preferably 5 mg / kg to 20 mg / kg is administered. In addition, the dose for prevention is preferably 5ppm or more in the feed and 5ppm to 20p.
Administer continuously at a concentration of pm.

実施例1 既に鶏回虫(Ascaridia galli)感染症に罹っているの
が確認されている鶏にキサントシリンXモノメチルエー
テルを1回経口投与してその鶏回虫感染症を治療した実
施例を次に示す。
Example 1 The following is an example in which xanthocillin X monomethyl ether was orally administered once to a chicken which had already been confirmed to have Ascaridia galli infection to treat the Ascaris suum infection.

一羽当たり体重60g前後の雛12羽に対し,回虫感染卵を
各羽約 200個宛経口感染させた。回虫の感染5週後,鶏
の糞便1g中の虫卵数(E.P.G.)を検査して確実に虫卵が
排泄されていることを確認して,3羽宛4群に分けた。
その4群はキサントシリンXモノメチルエーテル5mg/
kg投与群,10mg/kg投与群,20mg/kg投与群,残りの1
群は全くキサントシリンXモノメチルエーテルを投与し
ない無投与対照群とした。キサントシリンXモノメチル
エーテルは各鶏毎の体重から正確に計算した投与量だけ
を計量し,ゼラチンカプセルに充填し,これを,胃ゾン
デで強制的に経口投与した。これらの鶏は一羽毎に金網
製の鳥篭に入れ,金網敷きの床から落下する排泄物をス
テンレス製の受け皿に受け,投薬開始の当日から7日間
の間毎日排泄された子虫を丹念に数えると同時に体重と
一般状態を観察し,その観察の終了日に全ての鶏を解剖
して消化管内の内部寄生虫を全て計測して残存虫体数と
し,7日間に排泄された子虫数と合わせて排虫率を求め
た。その結果は表1,2に示す通りである。
Twelve chicks weighing around 60 g per bird were orally infected with about 200 Ascaris suum eggs. Five weeks after the infection with Ascaris, the egg count (EPG) in 1 g of chicken feces was examined to confirm that the eggs were excreted, and the eggs were divided into 4 groups of 3 birds.
The 4th group is xanthocillin X monomethyl ether 5mg /
kg administration group, 10 mg / kg administration group, 20 mg / kg administration group, remaining 1
The group was a non-administration control group to which no xanthocillin X monomethyl ether was administered. Xanthocillin X monomethyl ether was weighed in a dose exactly calculated from the body weight of each chicken, filled into a gelatin capsule, and this was forcibly orally administered by a gastric tube. Each of these chickens is placed in a wire cage bird cage, the excrement that falls from the wire mesh floor is received in a stainless steel saucer, and the larvae excreted every day for 7 days from the day when the drug is started are carefully treated. At the same time as counting, the weight and general condition were observed, and all chickens were dissected on the day of the end of the observation and all internal parasites in the digestive tract were measured to determine the number of remaining worms, and the number of offspring excreted in 7 days In addition, the insecticidal rate was calculated. The results are shown in Tables 1 and 2.

すなわち,排虫率は投与した薬物の駆虫効果をそのまま
表現する指数とみなされているので,まずその排虫率を
見ると,無投与対照群は3羽共排虫がなく,残存虫体数
のみであったのでその排虫率は0%であったのに対し,
5mg/kg投与群では平均8%,10mg/kg投与群では平均
69.7%,20mg/kgの投与群では平均 100%で完全に駆除
されており,投薬群の殆どでは投薬後2日間以内に殆ど
の子虫が排泄されていた。すなわち,10mg/kg以上の投
与量で顕著な効果が得られた。
In other words, the excretion rate is regarded as an index that directly expresses the anthelmintic effect of the administered drug. Therefore, first, looking at the excretion rate, the non-administration control group did not have three coexisting insects, and the number of residual insect bodies. Since the rate was 0%, it was 0%.
8% on average in the 5 mg / kg administration group, average in the 10 mg / kg administration group
In the 69.7% and 20 mg / kg administration groups, 100% of the animals were completely eradicated, and most of the medicated groups excreted most of the larvae within 2 days after the administration. That is, a remarkable effect was obtained at a dose of 10 mg / kg or more.

次に,体重変化を見ると,試験開始時と試験終了時の体
重の差から求めた増体率は投与対照群では平均22.4%で
あったのに対し5mg/kg投与群では平均20.6%,mg/kg
投与群では平均21.7%,20mg/kg投与群では平均24.3%
増加したので増体率は無投与対照群の増体率と比べ著差
はなく,一般状態にも著明な変化がなかった。
Next, looking at the change in body weight, the weight gain calculated from the difference in body weight between the start and end of the study was 22.4% on average in the administration control group, while it was 20.6% on average in the 5 mg / kg administration group. mg / kg
Mean 21.7% in the administration group, average 24.3% in the 20 mg / kg administration group
The increase in body weight was not significantly different from that in the untreated control group, and there was no significant change in general condition.

従って,この駆虫試験では10mg/kgないし20mg/kgの投
与量でキサントシリンXモノメチルエーテルの確実な駆
虫効果が確認された。
Therefore, in this anthelmintic test, a reliable anthelmintic effect of xanthocillin X monomethyl ether was confirmed at a dose of 10 mg / kg to 20 mg / kg.

発明の効果 表1,2に示したごとく,キサントシリンXモノメチル
エーテルを含有する駆虫剤は家畜の寄生虫に対し従来の
駆虫剤にくらべ極めて少量で簡便かつ確実な駆虫効果を
有する。
EFFECTS OF THE INVENTION As shown in Tables 1 and 2, the anthelmintic agent containing xanthocillin X monomethyl ether has a simple and reliable anthelmintic effect against parasites of livestock in an extremely small amount as compared with conventional anthelmintic agents.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 岡田 忠昭 神奈川県横浜市港北区師岡町760番地 明 治製菓株式会社薬品研究所内 (72)発明者 庄村 喬 神奈川県横浜市港北区師岡町760番地 明 治製菓株式会社薬品研究所内 (72)発明者 瀬崎 正次 神奈川県横浜市港北区師岡町760番地 明 治製菓株式会社薬品研究所内 (72)発明者 赤井 直利 神奈川県横浜市港北区師岡町760番地 明 治製菓株式会社薬品研究所内 (72)発明者 井上 重治 神奈川県横浜市港北区師岡町760番地 明 治製菓株式会社薬品研究所内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Tadaaki Okada 760 Shimooka-cho, Kohoku-ku, Yokohama-shi, Kanagawa Meiji Seika Co., Ltd. Pharmaceutical Research Laboratory (72) Inventor Taka Shomura 760, Shimo-oka-cho, Kohoku-ku, Yokohama, Kanagawa Haruka Seika Co., Ltd., Pharmaceutical Research Laboratory (72) Inventor, Shoji Sezaki, 760, Shimooka-cho, Kohoku-ku, Yokohama, Kanagawa Meiji Seika Chemicals Laboratory, (72) Inventor, Naoshi Akai, 760, Shimooka-cho, Kohoku-ku, Yokohama-shi, Kanagawa (72) Inventor Shigeharu Inoue, 760 Shimooka-cho, Kohoku-ku, Yokohama-shi, Kanagawa Meiji Confectionery Co., Ltd.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】キサントシリンXモノメチルエーテルを有
効成分として含有する動物用駆虫剤。
1. An anthelmintic agent for animals, which comprises xanthocillin X monomethyl ether as an active ingredient.
JP18672088A 1988-07-28 1988-07-28 Antiparasitic agent containing xanthocillin X monomethyl ether Expired - Lifetime JPH0621064B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP18672088A JPH0621064B2 (en) 1988-07-28 1988-07-28 Antiparasitic agent containing xanthocillin X monomethyl ether

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18672088A JPH0621064B2 (en) 1988-07-28 1988-07-28 Antiparasitic agent containing xanthocillin X monomethyl ether

Publications (2)

Publication Number Publication Date
JPH0240324A JPH0240324A (en) 1990-02-09
JPH0621064B2 true JPH0621064B2 (en) 1994-03-23

Family

ID=16193457

Family Applications (1)

Application Number Title Priority Date Filing Date
JP18672088A Expired - Lifetime JPH0621064B2 (en) 1988-07-28 1988-07-28 Antiparasitic agent containing xanthocillin X monomethyl ether

Country Status (1)

Country Link
JP (1) JPH0621064B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2495184A1 (en) 2002-08-14 2004-02-26 Nissan Chemical Industries, Ltd. Thrombopoietin receptor activators and process for their production
WO2006112413A1 (en) 2005-04-14 2006-10-26 Nissan Chemical Industries, Ltd. α-SUBSTITUTED VINYLTIN COMPOUND

Also Published As

Publication number Publication date
JPH0240324A (en) 1990-02-09

Similar Documents

Publication Publication Date Title
Burka et al. Drugs in salmonid aquaculture–a review
US7396819B2 (en) Anthelmintic formulations
US5935591A (en) Method for treatment of equine protozoal myeloencephalitis with thiazolides
Dorrestein et al. Pharmacotherapeutic aspects of medication of birds
US7582612B2 (en) Multi-action anthelmintic formulations
BG107038A (en) Composition against endopa gel
EP1306084A1 (en) Compositions for the control of parasitic infestations in fish
KR100236586B1 (en) 1-[n-(halo-3-pyridylmethyl)]-n-methylamino-2-nitroethylene derivatives for use against fleas on pets
JPH0621064B2 (en) Antiparasitic agent containing xanthocillin X monomethyl ether
RU2732293C1 (en) Supramolecular anthelmintic complex for treatment and prevention of animals with basic helminthiasis
UA74623C2 (en) Composition containing crystal modification of cyclic depsipeptide and method for combating endoparasites in animals
French et al. Eosinophilic colitis and hepatitis in a horse with colonic intramucosal ciliated protozoa
Dorrestein et al. Bioavailability and pharmacokinetics of ampicillin and amoxycillin from tablets, capsules and long‐acting preparations in the homing pigeon (Columba livia)
Stampa, S. & Terblanche Trials with Bayer 2353* and other drugs as cestocides for ruminants
JP7128466B2 (en) Effective remedy for downy mildew of marine fish and its administration method
SG175911A1 (en) Ectoparasiticidal methods and formulations
JPH055812B2 (en)
JPS5821615A (en) Preventive remedy for trematodiasis in grass-eating animals
Riviere et al. Sulfonamides
WO2005016356A1 (en) Improved anthelmintic formulations
Adil et al. Toxicity and Adverse Effects of Veterinary Pharmaceuticals in Animals
US3989840A (en) Control of animal parasites with ring-substituted N-(2,2-difluoroalkanoyl)-O-phenylenediamines
Arundel Cestode infections of domestic animals
Shafi et al. Immunosuppressive effect of ibuprofen in Japanese quails
US3466363A (en) Method of treating animals infected with large roundworms using cobalt arsenic compounds